The long-term objective of the proposed research is to determine the mechanisms of bidirectional transport across the nuclear pore complex. Transport in and out of the nucleus begins with recognition of the transported cargo by a dedicated set of transport receptors. After docking at the nuclear pore, the cargo-receptor complex moves through the pore channel, which is lined with nucleoporins. Loading and unloading of cargoes and interactions of the transported complexes with the nuclear pore are the defining events of nuclear transport. In many cases, the RanGTPase and its regulators controt the direction of movement through the pore. Targeting of large complexes such as the ribosome for export out of the nucleus imposes an even greater complexity on the process of nuclear transport.
The Specific Aims are to determine how: 1) ribosomes are exported out of the nucleus; 2) nuclear transport factors make contact with the nuclear pore complex; 3) the organization of the Ran regulators in the nucleus integrates nuclear transport and gene regulation; and 4) the integrity of the nuclear envelope is maintained. Defects in nuclear localization are associated with a number of diseases thus contributing to the health-relatedness of the project. Nuclear-cytoplasmic transport provides a mode of regulation for gene control in response to, for example, growth cues, stress, viral infection, immune response, and activity of tumor suppressors. The activity of certain proteins can be affected by altering their intraceltular location between the cytoplasm and the nucleus making nuclear transport a potential therapeutic target. In sum, understanding the process of nuclear transport and how it is regulated, may lead to new drug targets and ways to enhance viral-based gene therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM036373-23
Application #
7231694
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Shapiro, Bert I
Project Start
1993-06-01
Project End
2008-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
23
Fiscal Year
2007
Total Cost
$421,677
Indirect Cost
Name
Harvard University
Department
Biology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Wang, Qingqing; Moore, Michael J; Adelmant, Guillaume et al. (2013) PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth. Genes Dev 27:615-26
Adelmant, Guillaume; Calkins, Anne S; Garg, Brijesh K et al. (2012) DNA ends alter the molecular composition and localization of Ku multicomponent complexes. Mol Cell Proteomics 11:411-21
Lohmueller, Jason J; Armel, Thomas Z; Silver, Pamela A (2012) A tunable zinc finger-based framework for Boolean logic computation in mammalian cells. Nucleic Acids Res 40:5180-7
Haynes, Karmella A; Ceroni, Francesca; Flicker, Daniel et al. (2012) A sensitive switch for visualizing natural gene silencing in single cells. ACS Synth Biol 1:99-106
Boyle, Patrick M; Silver, Pamela A (2012) Parts plus pipes: synthetic biology approaches to metabolic engineering. Metab Eng 14:223-32
Smolke, Christina D; Silver, Pamela A (2011) Informing biological design by integration of systems and synthetic biology. Cell 144:855-9
Haynes, Karmella A; Silver, Pamela A (2011) Synthetic reversal of epigenetic silencing. J Biol Chem 286:27176-82
Senapedis, William T; Kennedy, Caleb J; Boyle, Patrick M et al. (2011) Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. Mol Biol Cell 22:1791-805
Burrill, Devin R; Silver, Pamela A (2011) Recording cellular experiences of DNA damage. Cell Cycle 10:2410-1
Burrill, Devin R; Silver, Pamela A (2011) Synthetic circuit identifies subpopulations with sustained memory of DNA damage. Genes Dev 25:434-9

Showing the most recent 10 out of 32 publications